drugset / Trial / NCT02403063

Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade

NCT02403063

Phase 4 Completed 18 enrolled Onze Lieve Vrouw Hospital
RandomizedParallel-groupQuadruple-blindBasic science

Summary

It was recently shown that neostigmine reversal was associated with increased atelectasis and that high-dose neostigmine was associated with longer postoperative length of stay and with an increased incidence of pulmonary edema and reintubation. These study results were consistent with findings from a previous epidemiological study which revealed an absence of beneficial effects of neostigmine on postoperative oxygenation and reintubation. In our previous study, the effects of neostigmine / glycopyrrolate and sugammadex on the electromyographic activity of the diaphragm showed beneficial effects for sugammadex. This could be explained by a possible effect on neuromuscular transmission at the muscle level, but can also be explained by a neostigmine-induced decrease in total nerve activity. In a study in cats, neostigmine has been shown to reduce efferent phrenic nerve activity. The investigators aim to show a difference in phrenic nerve activity between neostigmine and sugammadex, administered alone or in combination, in healthy male volunteers.

Timeline

Start
2015-09
Primary completion
2015-10
Completion
2015-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 50 ug/kg
Subject Sugammadex Other / unclassified 2 mg/kg

Indications

No indication recorded.